Evaluation of bone regeneration in rat calvaria using combination of enamel matrix derivate and bone graft substitute: a histological, histometric and immunohistochemical study
- PMID: 40323334
- DOI: 10.1007/s10006-025-01390-y
Evaluation of bone regeneration in rat calvaria using combination of enamel matrix derivate and bone graft substitute: a histological, histometric and immunohistochemical study
Abstract
Purpose: This study aimed to evaluate the bone repair process of standardized calvaria defects in rats treated with different bone substitute materials.
Methods: Critical size bone defects with 7 mm diameter were created in the right parietal bone of forty-eight rats using a trephine burr. The animals were randomly allocated to four different experimental groups according to the materials used to fill the defect, as follow: (1) Autogenous group: defects were filled with autogenous bone; (2) Bio-Oss group: defects were filled with demineralized bovine bone mineral; (3) EMD group: defects were filled with Emdogain®; and (4) EMD + Bone group: defects were filled with a combination of both Bone Ceramic® and Emdogain®. Euthanasia was performed after 30 and 60 days.
Results: Histometric analysis demonstrated for the 30-day period that all groups presented areas of bone neoformation, with the EMD + Bone group showing increased percentage of bone neoformation. For the 60-day period, there was a trend towards greater bone neoformation compared to the 30-day period, with a statistically significant difference between the EMD + Bone vs. Bio-Oss groups (p = 0.036). The percentage of new bone formation was significantly higher in the autogenous group compared to all the others. Moderate immunostaining of osteocalcin was observed in all groups at 30 days, which increased significantly in the 60-day period.
Conclusion: This study demonstrated suitable biological properties in the association of Emdogain® with Bone Ceramic®. However, further laboratory studies are needed to evaluate the osteoinductive properties of these materials, as well as their behavior in humans through clinical studies.
Clinical trial number: Not applicable.
Keywords: Biocompatible materials; Bone; Bone regeneration; Bone substitutes; Histology; Rats.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: This study received ethical approval from the Ethics Commission on Use of Animals (CEUA) of Araçatuba Dental School, Sao Paulo State University - UNESP (#Process 00921–2015) and followed all the ARRIVE guidelines. Competing interests: The authors declare no competing interests.
References
-
- Ferraz MP. An Overview on the Big Players in Bone Tissue Engineering: Biomaterials, Scaffolds and Cells. Int J Mol Sci 2024;25
-
- Szwed-Georgiou A, Plocinski P, Kupikowska-Stobba B, Urbaniak MM, Rusek-Wala P, Szustakiewicz K, Piszko P, Krupa A, Biernat M, Gazinska M, Kasprzak M, Nawrotek K, Mira NP, Rudnicka K (2023) Bioactive materials for bone regeneration: biomolecules and delivery systems. ACS Biomater Sci Eng 9:5222–5254 - PubMed - PMC - DOI
-
- de Almeida Malzoni CM, Pichotano EC, Freitas de Paula LG, de Souza RV, Okamoto R, Austin RS, Marcantonio E Jr., de Molon RS, Zandim-Barcelos DL (2023) Combination of leukocyte and platelet-rich fibrin and demineralized bovine bone graft enhanced bone formation and healing after maxillary sinus augmentation: a randomized clinical trial. Clin Oral Investig 27:5485–5498 - PubMed - DOI
-
- Pichotano EC, de Molon RS, de Souza RV, Austin RS, Marcantonio E, Zandim-Barcelos DL (2019) Evaluation of L-PRF combined with deproteinized bovine bone mineral for early implant placement after maxillary sinus augmentation: A randomized clinical trial. Clin Implant Dent Relat Res 21:253–262 - PubMed - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical